Geographical variation in the use of glucose‐lowering drugs in type‐2 diabetes in Denmark: A nationwide drug utilization study
The minor differences in the use of GLDs indicate equal access to GLDs across Denmark. Differences at the municipal level call for future studies to investigate if these reflect differences in clinical practice or differences in T2DM populations.
Authors
- Lotte Rasmussen (ORCID: https://orcid.org/0000-0001-5962-6647)
- Peter Bjødstrup Jensen (ORCID: https://orcid.org/0000-0001-5435-9092)
- Gitte Krogh Madsen (ORCID: https://orcid.org/0009-0000-4935-2339)
- Gesche Jürgens (ORCID: https://orcid.org/0000-0002-3317-8118)
- Stig Ejdrup Andersen (ORCID: https://orcid.org/0000-0002-1914-4720)
- Allan Kofoed‐Enevoldsen (ORCID: https://orcid.org/0000-0001-7051-1381)
- Jacob Harbo Andersen (ORCID: https://orcid.org/0000-0003-0656-6905)
- Anton Pottegård (ORCID: https://orcid.org/0000-0001-9314-5679)
Institutions
- Roskilde University (DK)
- Steno Diabetes Centers (DK)
- University of Southern Denmark (DK)
- Roskilde Sygehus (DK)
- Zealand University Hospital (DK)
- Capital Region of Denmark (DK)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1002/bcp.70343
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00